About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Primary Prophylaxis of Gastric Variceal Bleed

NCT02468180·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Xufeng Luo, MD
CONTACT
[email protected]

Lead

West China Hospital

Age

18–75

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

1. Cirrhosis
2. Patients with high risk gastric varices (GOV2 or IGV1)
3. Presence of gastrorenal shunt

You may not be if

1. Acute bleed or past history of bleed from gastric varices
2. Previous treatment of gastric varices.
3. Non-cirrhotic portal hypertension
4. Contraindications to cyanoacrylate injection or BRTO
5. Portal cavernoma
6. Hepatorenal syndrome
7. Proven malignancy including hepatocellular carcinoma
8. End-stage renal disease under renal replacement therapy;
9. Cardiorespiratory failure
10. Pregnancy or patients not giving informed consent for endoscopic procedures

The record

StatusUnknown

PhaseNo phase

Taking part70

StartedJun 2015

UpdatedNov 23, 2021

Conditions

Gastric Varices

Where1

West China Hospital
Chengdu, Sichuan, China

Clareo Health | Primary Prophylaxis of Gastric Variceal Bleed